 |
 |

Lymphomatoid Papulosis in Children
A Retrospective Cohort Study of 35 Cases
Tamar Nijsten, MD;
Clara Curiel-Lewandrowski, MD;
Marshall E. Kadin, MD
Arch Dermatol. 2004;140:306-312.
Background Lymphomatoid papulosis (LyP) is a rare entity, considered to be part of the spectrum of the CD30+ cutaneous lymphoproliferative disorders. About 10% to 20% of the adult LyP patients will develop an associated lymphoid malignancy. Only a few cases of LyP have been described in children, and the risk of associated lymphoid malignancies in these patients is not known.
Objectives To study the association between childhood onset of LyP and other malignancies and to determine the clinical characteristics in this subgroup of patients.
Design Retrospective cohort study.
Setting Referral center at a university hospital. Retrospective registry for patients with LyP of childhood onset ( 18 years).
Patients Thirty-five patients with childhood-onset LyP (19 boys and 16 girls) were interviewed by telephone using a standardized questionnaire. The median duration of follow-up was 9.0 years. All included patients were confirmed by histologic examination.
Results The age distribution was significantly different, with boys having an earlier onset of LyP (P = .03). Of the 35 LyP patients, 3 (9%) developed a malignant lymphoma; all were diagnosed as having non-Hodgkin lymphoma. Compared with the general population, patients with childhood-onset LyP have a significantly increased risk of developing non-Hodgkin lymphoma (relative risk, 226.2; 95% confidence interval, 73.4-697.0). More than two thirds of the patients reported being atopic, which is significantly more than the expected prevalence of atopy (relative risk, 3.1; 95% confidence interval, 2.2-4.3).
Conclusions Lymphomatoid papulosis presents similarly in children and adults, including the risk of lymphoid malignancies. Therefore, all LyP patients should be closely monitored throughout their lives.
From the Department of Dermatology (Drs Nijsten and Curiel-Lewandrowski), the Division of Hematology/Oncology, Cutaneous Oncology Program (Dr Curiel-Lewandrowski), and the Department of Pathology (Dr Kadin), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass. Drs Curiel-Lewandrowski and Nijsten equally contributed to this article. Dr Nijsten is now with the Department of Dermatology, University Hospital Antwerp, Edegem, Belgium. The authors have no relevant financial interest in this article.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Extranodal Marginal Zone B-Cell Lymphoma/Maltoma of the Lip in a Child: Case Report and Review of Cutaneous Lymphoid Proliferations in Childhood
Zambrano et al.
INT J SURG PATHOL 2006;14:163-169.
ABSTRACT
WHO-EORTC classification for cutaneous lymphomas
Willemze et al.
Blood 2005;105:3768-3785.
ABSTRACT
| FULL TEXT
Lymphomatoid Papulosis in Children Is Not Always Benign
Journal Watch Dermatology 2004;2004:2-2.
FULL TEXT
|